Synthetic Biologics Inc. (SYN): Odds are Looking Good after Recent Activity – Invest Chronicle

Synthetic Biologics Inc. (SYN): Odds are Looking Good after Recent Activity

Let’s start up with the current stock price of Synthetic Biologics Inc. (SYN), which is $0.26 to be very precise. The Stock rose vividly during the last session to $0.28 after opening rate of $0.28 while the lowest price it went was recorded $0.25 before closing at $0.28.Recently in News on December 14, 2021, Synthetic Biologics Announces Planned Transformative Acquisition of VCN Biosciences; Developer of a Novel Oncolytic Virus Platform Targeting Pancreatic and other Solid Tumors. Lead drug candidate VCN-01 demonstrated clinical activity in multiple Phase 1 clinical trials. You can read further details here

Synthetic Biologics Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $0.3100 on 01/04/22, with the lowest value was $0.2526 for the same time period, recorded on 01/13/22.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


Synthetic Biologics Inc. (SYN) full year performance was -65.70%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Synthetic Biologics Inc. shares are logging -78.69% during the 52-week period from high price, and 1.96% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.25 and $1.22.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1663771 for the day, which was evidently lower, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Synthetic Biologics Inc. (SYN) recorded performance in the market was -4.48%, having the revenues showcasing -40.46% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 34.33M, as it employees total of 10 workers.

Specialists analysis on Synthetic Biologics Inc. (SYN)

According to the data provided on, the moving average of the company in the 100-day period was set at 0.3967, with a change in the price was noted -0.19. In a similar fashion, Synthetic Biologics Inc. posted a movement of -42.67% for the period of last 100 days, recording 1,753,949 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for SYN is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.

>> 7 Top Picks for the Post-Pandemic Economy << 

Trends and Technical analysis: Synthetic Biologics Inc. (SYN)

Raw Stochastic average of Synthetic Biologics Inc. in the period of last 50 days is set at 3.67%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 9.20%. In the last 20 days, the company’s Stochastic %K was 25.80% and its Stochastic %D was recorded 27.53%.

Now, considering the stocks previous presentation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -4.48%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -47.47%, alongside a downfall of -65.70% for the period of the last 12 months. The shares increased approximately by -5.18% in the 7-day charts and went up by -13.68% in the period of the last 30 days. Common stock shares were lifted by -40.46% during last recorded quarter.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts